Wilmer Cutler Pickering Hale and Dorr advised Ratio Therapeutics Inc in the transaction. Ratio Therapeutics Inc, a pharmaceutical company, announced its exclusive worldwide license and collaboration...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised MicroStrategy Incorporated in the offering, and Davis Polk & Wardwell advised Barclays Capital, Inc., as representatives of the initial...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented State Street Bank and Trust Company in the offering. State Street Corporation (“State Street”) (NYSE: STT) announced that its...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr is representing Verde Bioresins, Inc. in the transaction, and Snell & Wilmer is representing Nxu Inc. Verde Bioresins, Inc., a...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale advised MicroStrategy Incorporated, and Davis Polk advised the Agents on the offering. MicroStrategy Incorporated (MicroStrategy) (Nasdaq: MSTR) announced the company’s new at-the-market...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented State Street Corporation in the offering, and Cravath, Swaine & Moore represented the underwriters. State Street Corporation (“State Street”)...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented CH Investment Partners in the transaction. Cresset Asset Management (“Cresset”) , an independent investment firm, announced its acquisition of...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented McCormick & Company, Incorporated in the offering, and Weil, Gotshal & Manges represented the underwriters. McCormick & Company, Incorporated...
You must be a Standard 1 Year member to access this content.
Ropes & Gray, Hogan Lovells, Yetter Coleman and Wilmer Cutler Pickering Hale and Dorr assisted Welsh, Carson, Anderson & Stowe in the case, while Kellogg, Hansen,...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Telix Pharmaceuticals Limited in the transaction. Telix Pharmaceuticals Limited (ASX: TLX) (Telix), a biopharmaceutical company, announced its acquisition of...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Nuvalent, Inc. in the offering, and Simpson Thacher & Bartlett represented the underwriters. Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised MicroStrategy Incorporated in the offering, and Davis Polk & Wardwell advised the representative of the several initial purchasers. MicroStrategy...
You must be a Standard 1 Year member to access this content.
